Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial
Atefi et al., Immunity, Inflammation and Disease, doi:10.1002/iid3.1083
https://c19early.org/atefiaz.html